Literature DB >> 9292519

The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor.

P T Jubinsky1, O I Krijanovski, D G Nathan, J Tavernier, C A Sieff.   

Abstract

Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors share a common beta chain (beta(c)), and both cytokines enhance erythropoietin (Epo)-dependent in vitro erythropoiesis by primary hematopoietic progenitors and factor-dependent cells. These data suggest that the Epo receptor and beta(c) may functionally interact. To determine whether such interactions can be documented, we studied a murine factor-dependent cell line (Ba/F3), which endogenously expresses IL-3R. First, Ba/F3 cells were transfected with murine EpoR, making them responsive to both IL-3 and Epo. Next, the EpoR expressing cells were transfected with murine beta(c). This resulted in an enhanced sensitivity of these cells to Epo, which was especially pronounced at low Epo concentrations. Ba/F3-EpoR were then treated with antisense oligodeoxynucleotides to the murine beta. Control sense and nonsense had no effect on Epo-dependent growth, but the antisense markedly and specifically inhibited Epo-dependent growth. In contrast, the antisense did not affect beta-globin message levels (another Epo-responsive effect in these cells) detectable by Northern blot. Finally, Western blot analysis of proteins immunoprecipitated from cells expressing both receptors with antibody against beta and blotted with antibody against EpoR, or immunoprecipitated with antibody against EpoR and blotted with antibody against beta, showed that EpoR and beta coimmunoprecipitate. These data show that the beta chain functionally and physically associates with the EpoR. This suggests that these cytokine receptors exist as a large supercomplex and offers the first molecular explanation for the synergistic effects of IL-3 and GM-CSF with Epo during erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292519

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse.

Authors:  Tim Sullivan; Kishore Kodali; Tonia S Rex
Journal:  Neurochem Res       Date:  2010-10-06       Impact factor: 3.996

2.  Exploration of early-life candidate biomarkers for childhood asthma using antibody arrays.

Authors:  Haili Xu; Timothy Radabaugh; Zhenqiang Lu; Michael Galligan; Dean Billheimer; Donata Vercelli; Anne L Wright; Terrence J Monks; Marilyn Halonen; Serrine S Lau
Journal:  Pediatr Allergy Immunol       Date:  2016-09-12       Impact factor: 6.377

3.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

4.  Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells.

Authors:  Emilia Stellacci; Antonella Di Noia; Angela Di Baldassarre; Giovanni Migliaccio; Angela Battistini; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2009-05       Impact factor: 3.084

5.  When erythropoietin meddles in immune affairs.

Authors:  Frank Martinez; Nicolas Pallet
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

6.  Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats.

Authors:  R J Macias-Velez; L Fukushima-Díaz de León; C Beas-Zárate; M C Rivera-Cervantes
Journal:  J Mol Neurosci       Date:  2019-05-03       Impact factor: 3.444

Review 7.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

8.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

9.  Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Authors:  Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Hand; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

10.  Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria.

Authors:  Isabelle M Medana; Nicholas P J Day; Tran Tinh Hien; Nicholas J White; Gareth D H Turner
Journal:  Malar J       Date:  2009-11-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.